Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD20 antibody variable domain is fused to the C terminal of an IgG of anti-CD22 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY